19-09-2022 17:30 via medpagetoday.com

RDN Powers Through Another Off-Med Trial, Clinical Benefits Still Untested

(MedPage Today) -- BOSTON--Endovascular renal denervation (RDN) continued to lower blood pressure (BP) in different populations regardless of the specific technology used, according to two late-breaking trial presentations here at the Transcatheter...
Read more »